Skip to Content

Join the 'HIV Infection' group to help and get support from people like you.

HIV Infection News

Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS

Alcohol More Harmful for People With HIV, Study Suggests

Posted 5 days ago by

MONDAY, Feb. 8, 2016 – Drinking alcohol may be more dangerous for people infected with HIV, a new study suggests. The effects of alcohol appear to be more pronounced for those with the virus that causes AIDS, even when the virus is suppressed with modern antiretroviral treatment (ART), the Yale University researchers reported. They noted that HIV patients who have just one or two drinks a day are at greater risk for death or alcohol-related health issues. The study involved patients treated by the U.S. Department of Veterans Affairs between 2008 and 2012. There were more than 18,000 HIV-positive patients and over 42,000 people not infected with the virus. The researchers investigated the link between drinking alcohol, death and other health issues the patients developed. They found the patients with HIV who drank even moderate amounts of alcohol were more likely to develop ... Read more

Related support groups: HIV Infection, Alcohol Dependence, Tamiflu, Incivek, Alcoholism, Pre-Exposure Prophylaxis, Hangover, Baraclude, Victrelis, Viread, Oseltamivir, Tenofovir, Kaletra, Entecavir, Norvir, Telaprevir, Reyataz, Boceprevir, Nevirapine, Lamivudine

CDC: Black Americans With HIV Still Less Likely to Get Ongoing Medical Care

Posted 8 days ago by

FRIDAY, Feb. 5, 2016 – While HIV diagnoses dropped significantly over the past decade in the United States, blacks with HIV are less likely than whites or Hispanics to receive routine, ongoing care, according to the U.S. Centers for Disease Control and Prevention. From 2005 to 2014, annual HIV diagnoses fell 19 percent in the United States. Infections among black women dropped 42 percent during this period. Despite this progress in the fight against HIV, racial disparities persist, the CDC found. While black people make up 12 percent of the U.S. population, they accounted for nearly half of all HIV diagnoses in 2014. "CDC has been working for many years to eliminate the HIV disparities that exist within the black community," Dr. Eugene McCray, director of the CDC's Division of HIV/AIDS Prevention, said in an agency news release. "While we are seeing signs of success, we must continue ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Tamiflu, Incivek, Pre-Exposure Prophylaxis, Truvada, Triumeq, Stribild, Baraclude, Complera, Victrelis, Oseltamivir, Kaletra, Viread, Tenofovir, Norvir, Entecavir, Telaprevir, Boceprevir

Scientists Piggyback Experimental HIV Vaccine on Cold Viruses

Posted 11 days ago by

TUESDAY, Feb. 2, 2016 – Scientists report progress in their bid to develop ways to piggyback an HIV vaccine on germs that cause colds. In the new study, Harvard researchers said they successfully used cold viruses to deliver an experimental HIV vaccine to humans. The approach "appears to be safe and well-tolerated, and the injection induces a moderate immune response against HIV in humans," said Dr. James Crowe, director of Vanderbilt Vaccine Center in Nashville. He was not involved in the study. The research doesn't mean that a long-sought HIV vaccine is near; these scientists focused on developing better ways to deliver a potential vaccine into the immune system. Researchers have long sought to develop a vaccine against HIV, but the virus is especially stubborn. "Most experimental vaccines tested to date don't seem to induce strong or protective immune responses," Crowe said. Even ... Read more

Related support groups: HIV Infection, Cold Symptoms, Pre-Exposure Prophylaxis, Vaccination and Prophlaxis

Resistance to HIV Drug Growing, Study Finds

Posted 15 days ago by

FRIDAY, Jan. 29, 2016 – HIV resistance to the antiretroviral drug tenofovir (Viread) is increasingly common, a new study finds. The researchers said their finding is surprising and alarming because the drug plays a major role in treating and preventing infection with HIV, the virus that causes AIDS. "Tenofovir is a critical part of our armamentarium against HIV, so it is extremely concerning to see such a high level of resistance to this drug," study author Dr. Ravi Gupta, from the department of infection and immunity at University College London in England, said in a university news release. "It is very potent drug with few side effects, and there aren't any good alternatives that can be deployed using a public health approach. Tenofovir is used not only to treat HIV but also to prevent it in high-risk groups, so we urgently need to do more to combat the problem of emerging ... Read more

Related support groups: HIV Infection, Atripla, Pre-Exposure Prophylaxis, Truvada, Viral Infection, Stribild, Complera, Viread, Tenofovir, Emtricitabine/Tenofovir, Emtricitabine/lopinavir/ritonavir/tenofovir, Emtricitabine/rilpivirine/tenofovir, Cobicistat/elvitegravir/emtricitabine/tenofovir, Efavirenz/Emtricitabine/Tenofovir, Genvoya, Emtricitabine/nelfinavir/tenofovir

HIV Can Persist in Body Despite Drug Therapy

Posted 17 days ago by

WEDNESDAY, Jan. 27, 2016 – Even when blood tests of HIV patients on antiretroviral drugs show no sign of the AIDS-causing virus, it can still be replicating in lymphoid tissue, researchers report. The study offers important new insight into how HIV persists in the body despite treatment with the powerful drugs, according to the team of international researchers led by Northwestern University's Feinberg School of Medicine in Chicago. To reach their finding, they examined viral sequences in samples of lymph node and blood cells from three HIV-infected patients who had no detectable virus in their blood. And what they found was that a viral reservoir in lymphoid tissue, which scientists believed held long-lived infected cells in a resting state, was being constantly replenished with infected cells. "The challenge is to deliver drugs at clinically effective concentrations to where the ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Sovaldi, Incivek, Pre-Exposure Prophylaxis, Truvada, Triumeq, Stribild, Baraclude, Complera, Victrelis, Sofosbuvir, Viread, Kaletra, Tenofovir, Norvir, Entecavir, Telaprevir, Viekira Pak

New Approach Might Boost HIV Testing Rates

Posted 20 Jan 2016 by

WEDNESDAY, Jan. 20, 2016 – Telling people they'll be screened for HIV unless they decline to be tested – an approach known as "opt-out" testing – could significantly increase the number of patients who agree to be tested, new research suggests. Other approaches to HIV screening, such as leaving it up to patients to specifically ask to be tested, could have the opposite effect, researchers said. "Our study provides evidence that small changes in wording can significantly affect patients' behavior and thus our understanding of their preferences and is crucial to providing patient centered care," wrote study leader Juan Carlos Montoy, from the University of California, San Francisco, and colleagues. The study, which involved 4,800 patients seen in the emergency room, is the first randomized controlled trial to evaluate consent for HIV testing. None of the patients involved had ever ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Diagnosis and Investigation

HIV Testing Rates Still Low Among Teens, Young Adults: CDC

Posted 19 Jan 2016 by

TUESDAY, Jan. 19, 2016 – Only one in five sexually active high school students has been tested for HIV, and young adults aren't doing much better at finding out their status, U.S. health officials report. As a result, an estimated 50 percent of young Americans infected with the virus that causes AIDS don't know they have it, the researchers found. "We haven't made the dent that we would like to have made," said study author Michelle Van Handel, a health scientist with the division of HIV/AIDS prevention at the U.S. Centers for Disease Control and Prevention. In fact, she said, the HIV testing rate is actually lower among those aged 18 to 24 than for older people in the United States. Thanks to medical advances, HIV has evolved into a chronic disease instead of a fatal one. But those who are infected must take medications for their entire lives and face higher risk of various health ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Diagnosis and Investigation

New HIV Treatment Shows Promise in Early Research

Posted 23 Dec 2015 by

WEDNESDAY, Dec. 23, 2015 – Preliminary new research raises the prospect that a recently discovered antibody – an important component of the immune system – could be enlisted to boost the body's response to HIV, the virus that causes AIDS. A single injection of the antibody, currently dubbed VRC01, dramatically reduced the level of HIV in the blood of people who hadn't yet been given antiretroviral drug treatment (ART). ART is the current standard treatment for managing HIV infections, according to the study's authors from the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases in Bethesda, Md. But in people who'd already been treated with ART, the antibody injection had no effect on HIV levels, presumably because the ART therapy had already reduced the levels of HIV virus in their blood, the researchers said. And the researchers were quick to note ... Read more

Related support groups: HIV Infection, Valtrex, Acyclovir, Tamiflu, Ribavirin, Valacyclovir, Incivek, Pre-Exposure Prophylaxis, Zovirax, Baraclude, Victrelis, Famciclovir, Famvir, Viread, Kaletra, Tenofovir, Oseltamivir, Valcyte, Norvir, Ribasphere

FDA Lifts Ban on Blood Donations by Gay Men

Posted 21 Dec 2015 by

MONDAY, Dec. 21, 2015 – Gay and bisexual men who have abstained from sex for one year will now be allowed to donate blood in the United States. The new policy, announced Monday by the U.S. Food and Drug Administration, reverses a three-decades-old ban on donations from this group of men that traces back to the start of the AIDS epidemic. "The FDA's responsibility is to maintain a high level of blood product safety for people whose lives depend on it," FDA Acting Commissioner Stephen Ostroff said in an agency news release. "We have taken great care to ensure this policy revision is backed by sound science and continues to protect our blood supply." The FDA said it was changing its policy based on data from other countries that show allowing such donations would not increase the risk of HIV-tainted blood entering America's blood supply. FDA officials have estimated that about half of the ... Read more

Related support groups: Blood Disorders, Bleeding Disorder, Harvoni, HIV Infection, Valtrex, Acyclovir, Anemia, Atripla, Tamiflu, Ribavirin, Valacyclovir, Incivek, Pre-Exposure Prophylaxis, Zovirax, Blood Transfusion, Truvada, Triumeq, Stribild, Baraclude, Victrelis

CDC: Too Few Schools Teach Prevention of HIV, STDs, Pregnancy

Posted 9 Dec 2015 by

WEDNESDAY, Dec. 9, 2015 – Too few U.S. schools teach students how to protect themselves from HIV and other sexually transmitted diseases, how to prevent pregnancy, and other important sexual health information, federal officials reported Wednesday. In most of the country, fewer than half of high schools and only one-fifth of middle schools teach all 16 sexual health education topics recommended by the U.S. Centers for Disease Control and Prevention. In 44 states, the proportion of high schools that teach all 16 topics in grades 9, 10, 11 or 12 ranges from 21 percent in Arizona to 90 percent in New Jersey. Only three states – New Hampshire, New Jersey and New York – have more than 75 percent of high schools teaching all of the topics. The proportion of middle schools that teach all 16 topics in grades 6, 7 or 8 ranges from 4 percent in Arizona to 46 percent in North Carolina. No state ... Read more

Related support groups: Birth Control, Contraception, Plan B, Emergency Contraception, Mirena, Sprintec, NuvaRing, Implanon, Provera, Nexplanon, Depo-Provera, Tri-Sprintec, Ortho Tri-Cyclen, Yasmin, Microgestin Fe 1/20, Loestrin 24 Fe, Ortho Evra, Lutera, TriNessa, Plan B One-Step

Risky Sexual Behaviors Put Many Young Gay Men at Risk of HIV: Study

Posted 7 Dec 2015 by

MONDAY, Dec. 7, 2015 – Young American gay and bisexual men who have detectable blood levels of HIV – the virus that causes AIDS – are also more likely to engage in risky sexual behavior that might spread the virus, a new study has found. "While many of these young men are engaged in care, and success stories are many, we still have work to do to reduce the rate of new infections," study author Patrick Wilson, an assistant professor of sociomedical sciences at Columbia University's Mailman School of Public Health in New York City, said in a university news release. Different strategies to help prevent HIV infections and promote safe sex are needed for this group, his team wrote in the Dec. 7 issue of the journal JAMA Pediatrics. According to the researchers, young men between the ages of 13 and 29 who are gay or bisexual are particularly vulnerable to infection with HIV and now ... Read more

Related support groups: Birth Control, Contraception, Emergency Contraception, Harvoni, HIV Infection, Postcoital Contraception, Atripla, Incivek, Pre-Exposure Prophylaxis, Truvada, Triumeq, Stribild, Baraclude, Complera, Victrelis, Tenofovir, Kaletra, Viread, Norvir, Entecavir

HIV Rates Fall, But Not All Groups Benefit, U.S. Study Finds

Posted 7 Dec 2015 by

MONDAY, Dec. 7, 2015 – The number of Americans diagnosed with HIV each year declined by about one-fifth during the past decade, but not all groups saw drops in prevalence, a federal government study shows. Between 2005 and 2014, the overall annual number of HIV diagnoses fell 19 percent – from nearly 48,800 to just over 39,700 a year. The drop was led by a 63 percent decline among injection drug users, a 42 percent drop among black women, and a 35 percent decrease among heterosexuals. However, annual HIV diagnoses among gay and bisexual men actually rose about 6 percent during the study period, from about 25,000 to just over 26,600 a year, although they recently stabilized at less than a 1 percent increase a year. The increase in HIV diagnoses among gay and bisexual men was driven largely by blacks and Hispanics, the U.S. Centers for Disease Control and Prevention report found. HIV ... Read more

Related support groups: Harvoni, HIV Infection, Atripla, Incivek, Truvada, Triumeq, Baraclude, Stribild, Victrelis, Complera, Kaletra, Viread, Tenofovir, Entecavir, Norvir, Telaprevir, Viekira Pak, Nevirapine, Diagnosis and Investigation, Reyataz

Screen All Kids for Cholesterol, Depression and HIV, Pediatricians' Group Says

Posted 7 Dec 2015 by

MONDAY, Dec. 7, 2015 – All kids should be screened for high cholesterol, depression and HIV, with some tests starting as early as age 9, a leading group of U.S. pediatricians recommends. The guidelines, from the American Academy of Pediatrics, are among some key steps the academy has recently taken to advise pediatricians on child health screenings. A summary of the recommendations is published Dec. 7 in the journal Pediatrics. A recurring theme is that screenings are recommended for all children in certain age groups – and not only for those who might be at increased risk. For example, all kids should be screened for high cholesterol between the ages of 9 and 11. At one time, screening was done only when children were considered to be high-risk, based on factors like family history, said Dr. Geoffrey Simon, who chairs the academy's Committee on Practice and Ambulatory Medicine. But ... Read more

Related support groups: Depression, Major Depressive Disorder, High Cholesterol, HIV Infection, Dysthymia, Hypertriglyceridemia, Diagnosis and Investigation

Transgender Transition Costs Make Economic Sense: Study

Posted 5 Dec 2015 by

FRIDAY, Dec. 4, 2015 – Sex reassignment surgery and hormone treatment for transgender men and women is cost-effective, a new study indicates. "Providing health care benefits to transgender people makes economic sense," study leader William Padula, an assistant professor of health policy and management at Johns Hopkins School of Medicine in Baltimore, said in a university news release. Most U.S. health plans don't pay for these treatments, but this Johns Hopkins-led investigation found that surgery and hormone treatment doesn't cost much more than treatment for depression, substance abuse and HIV/AIDS. These health problems are common among transgender people who can't undergo medical transition, according to the authors of the study published online recently in the Journal of General Internal Medicine. In the first five years, the cost of sex reassignment surgery and hormone treatment ... Read more

Related support groups: Depression, Surgery, HIV Infection, Dysthymia, Gender Dysphoria, Vascular Surgery, Genitourinary Surgical and Other Conditions

HIV Prevention Pill May Not Need to Be Taken Daily

Posted 1 Dec 2015 by

TUESDAY, Dec. 1, 2015 – New research suggests that men at risk for HIV, the virus that causes AIDS, can benefit from a preventive medication taken before and after sex instead of every day. The findings offer more support for so-called pre-exposure prophylaxis, better known as PrEP, which has become popular in the gay male community. "Our study provides an alternative choice for gay men. They can use PrEP either daily or on demand," said study lead author Dr. Jean-Michel Molina, a professor of infectious diseases at the University of Paris Diderot. However, PrEP is not a guarantee against HIV infection, and it must be taken properly to provide protection, the researchers stressed. Two participants in the study who were offered the medication, known as Truvada, developed HIV because they failed to follow directions, the study authors said. The study was released online Dec. 1 in the New ... Read more

Related support groups: HIV Infection, Pre-Exposure Prophylaxis, Truvada

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Pre-Exposure Prophylaxis, Viral Infection

Related Drug Support Groups

Atripla, Truvada, Triumeq, Stribild, Complera, Kaletra, Viread, tenofovir, Norvir, view more... Reyataz, nevirapine, lamivudine, Lexiva, Norvir Soft Gelatin, abacavir, Epivir, Combivir, Prezista, Tivicay, Sustiva, Trizivir, Privigen, indinavir, Sandoglobulin, efavirenz, immune globulin intravenous, ritonavir, didanosine, dolutegravir, abacavir / dolutegravir / lamivudine, Telzir, Ziagen, Retrovir, Agenerase, Fuzeon, Carimune, Carimune NF, lamivudine / zidovudine, nelfinavir, Epzicom, Prezcobix, darunavir, amprenavir, atazanavir, stavudine, Edurant, raltegravir, Intelence, Isentress, zidovudine, Genvoya, Octagam, Venoglobulin-S 5%, Evotaz, Gammagard S / D, Zerit XR, Selzentry, Venoglobulin-S 10%, Dutrebis, Gamimune, Tybost, Viramune XR, Gamimune N 10%, Panglobulin, Iveegam En, Gamimune N 5%, Gammaplex, Gammar IV, Vitekta, Polygam S / D, Gammar-P IV, Crixivan, zalcitabine, tipranavir, saquinavir, etravirine, emtricitabine / lopinavir / ritonavir / tenofovir, emtricitabine / rilpivirine / tenofovir, rilpivirine, emtricitabine / nelfinavir / tenofovir, maraviroc, lopinavir / ritonavir, delavirdine, abacavir / lamivudine / zidovudine, abacavir / lamivudine, efavirenz / emtricitabine / tenofovir, emtricitabine, fosamprenavir, enfuvirtide, emtricitabine / tenofovir, cobicistat / elvitegravir / emtricitabine / tenofovir, elvitegravir, Fortovase, Viramune, Viracept, Invirase, Zerit, Flebogamma, Hivid, Aptivus, Epivir-HBV, Emtriva, cobicistat / darunavir, atazanavir / cobicistat, cobicistat, lamivudine / raltegravir, Rescriptor, Videx EC, Videx, Panglobulin NF